XML 57 R44.htm IDEA: XBRL DOCUMENT v3.23.3
SHARE-BASED PAYMENTS - Schedule of Share-based Compensation, Restricted Stock, Restricted Stock Units Activity and SAR's (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Payment Arrangement, Expense $ 1,293 $ 1,282 $ 4,033 $ 3,291
Equity Option        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 4.12  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 3.96   $ 3.96  
Employee Stock Option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Payment Arrangement, Expense $ 117 98 $ 311 239
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Unrecognized Compensation Costs Related To Unvested Stock Options     280  
Restricted Stock Units (RSUs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Payment Arrangement, Expense $ 523 618 $ 2,329 1,589
Restricted Stock Units (RSUs) | Equity Option        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]        
Number of nonvested shares, beginning of period (in shares)     747,425  
Granted, nonvested, number of shares (in shares)     450,232  
Vested, number of shares (in shares)     (448,883)  
Forfeited, number of shares (in shares)     (51,329)  
Number of nonvested shares, end of period (in shares) 697,445   697,445  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 4.77  
Granted, nonvested, weighted average grant date fair value (in dollars per share)     7.36  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     7.23  
Vested, weighted average grant date fair value (in dollars per share)     4.24  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 6.60   $ 6.60  
Stock Appreciation Rights (SARs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Payment Arrangement, Expense $ 653 $ 566 $ 1,393 $ 1,463
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]        
Number of nonvested shares, beginning of period (in shares)     2,452,768  
Granted, nonvested, number of shares (in shares)     308,333  
Exercised, number of shares (in shares)     (546,636)  
Forfeited, number of shares (in shares)     (42,510)  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations     0  
Number of nonvested shares, end of period (in shares) 2,171,955   2,171,955  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 4.07  
Granted, nonvested, weighted average grant date fair value (in dollars per share)     7.36  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercised, Weighted Average Exercise Price     2.92  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     7.24  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expired, Weighted Average Grant Date Fair     0  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 4.76   $ 4.76  
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Number 545,507   545,507  
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price $ 2.92   $ 2.92  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms     1 year 10 months 28 days  
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Remaining Contractual Term     3 months 21 days  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $ 7,508   $ 7,508  
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Aggregate Intrinsic Value $ 2,891   $ 2,891  
Stock Appreciation Rights (SARs) | Equity Option        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]        
Number of nonvested shares, beginning of period (in shares)     1,360,625  
Granted, nonvested, number of shares (in shares)     308,333  
Vested, number of shares (in shares)     0  
Forfeited, number of shares (in shares)     (42,510)  
Number of nonvested shares, end of period (in shares) 1,626,448   1,626,448  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 2.81  
Granted, nonvested, weighted average grant date fair value (in dollars per share)     3.45  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     3.68  
Vested, weighted average grant date fair value (in dollars per share)     0  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 2.91   $ 2.91